The beginning of a new trading week brings new possibilities with it and it may be a good time for investors to start tracking new stocks. There are hundreds upon hundreds of stocks in the market that could be worth following for a wide range of reasons and it is next to impossible for any investor to keep track of those many stocks. Hence, there is a necessity to be selective when it comes to choosing stocks to track and follow. This article provides you with a fairly detailed look into three stocks that could be worth putting on your watch list for the week.
Pressure BioSciences Inc (OTC:PBIO) – Pressure BioSciences Inc, which is best known for developing pressure-based instruments that can be deployed across a range of industries, was in focus last Thursday. On that day, the company announced its financial results for the first fiscal quarter that ended on March 31, 2022, and it may be a good move to consider taking a look at some of the key highlights. In the quarter, the revenues came in at $480,000 and that proved to be 14% lower than the revenues of $560,000 in the prior-year period.
On the other hand, instrument sales also dropped and declined by 19% to hit $465,000. In the prior-year period, the total instrument sales stood at $553,800. Operating losses, on the other hand, went up by 1% and hit $1,086,000 as compared to $1,075,000 in the prior-year period. It remains to be seen if the Pressure BioSciences stock comes into action today.
RushNet Inc (OTC:RSHN) – There has been no news about RushNet Inc for quite some time until the company made a key announcement back on May 20 and that could bring the company’s stock back into focus among investors. On that day, the company announced that it was going to have a debt restructuring for the existing lab acquisition from its subsidiary heliosDX. According to the provisions of the agreement, it was decided that heliosDX would be required to make a monthly payment of as much as $64,000 against the debt, and on top of that, a balloon payment is going to become due at some point in 2024.
The laboratory had the original price of $6 million and after taking into account the amortization schedule, the balance of the debt for heliosDX stands at $4,400,000. However, more importantly, the debt restructuring is going to give heliosDX considerable legroom since it defer the payment up until March next year.
GTX Corp (OTC:GTXO) – As the earnings season continues, there may be certain companies that may be worth looking into, and GTX Corp, which announced its financial results on May 19, could be one of those. The wearable GPS products company had a bit of a mixed quarter and actually saw its revenues decline by as much as 27% year on year.
However, on the other hand, the company recorded higher gross margins of as much as 42%. In the prior-year period, the gross margins had stood at 36%. In addition to that, it is interesting to note that the expenses of GTX Corp on benefits, wages, and miscellaneous profession fees actually decline by 2% on a year-on-year basis. It remains to be seen if the stock comes into focus today or not.
